CAPITOL COUNSEL LLC

Lobbying for ARDELYX, INC. · Biopharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Jan 19, 2026

Lobbying activity 2

Health Issues

Issues regarding ESRD-related drugs and the Medicare ESRD prospective payment system.

Medicare/Medicaid

Issues regarding ESRD-related drugs and the Medicare ESRD prospective payment system.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.